On Thursday, Dec. 20, President Trump signed the 2018 Farm Bill into law. The bill passed out of the House last week with a vote of 369-47 and passed the Senate on Tuesday with an 87-13 vote.

Among its many agricultural measures, the bill removes hemp from the Controlled Substances Act – effectively legalizing hemp and hemp-derived cannabidiol production. NCPA supported and lobbied for this provision as it could provide a boost to selling CBD products at independent pharmacies across the country.

Trump signed the Farm Bill today, which legalized industrial hemp. Here’s what that will mean for the exploding CBD market https://t.co/za8fDuLOuY pic.twitter.com/qtxOqUjPKn

— Rolling Stone (@RollingStone) December 20, 2018

With CBD products no longer being labeled as a Schedule 1 controlled substance, there should now be lesser concern for state boards of pharmacy – some of whom have previously hesitated allowing the sale of CBD products due to the potential conflicts between state and federal law.

A reminder of Kansas law on CBD oil: If a pharmacy can prove that the product is actually CBD oil and that it contains no (0.00%) THC, then it is not a product covered by BOP regulation.